Tyner; Jeffrey W.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Tyner; Jeffrey W..The latest application filed is for "treatment for venetoclax-resistant and venetoclax-sensitive acute myeloid leukemia".
- Tyner; Jeffrey W. - Portland OR
- Tyner; Jeffrey W - Portland OR
| Patent | Date |
|---|---|
| Treatment For Venetoclax-resistant And Venetoclax-sensitive Acute Myeloid Leukemia App 20210353619 - Tyner; Jeffrey W. ; et al. | 2021-11-18 |
| Treatments For Mutations In Acute Myeloid Leukemia App 20210235374 - Tyner; Jeffrey W ; et al. | 2021-07-29 |
| Ror1 As A Gene Target In Acute Lymphoblastic Leukemia App 20130131139 - Tyner; Jeffrey W. ; et al. | 2013-05-23 |
| Selection Of Personalized Cancer Therapy Regimens Using Interfering Rna Functional Screening App 20090312194 - TYNER; JEFFREY W. ; et al. | 2009-12-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 